{"article":{"annotation":{"article_id":"gsk-third-quarter-sales-total-core-profit-currency-2026","available_at":"2026-10-28T19:46:27.657949Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"f74f4ebabc1c55a6bdf205ca051e5542fc372efcee5987da21874f9e6d3749a5","input_sha256":"735d074d15bafd9940fbea2ecb92c031ae9d9a9de22c14ee484c8244a6197cd9","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"GB","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"]}],"geometry":null,"id":"iso3166-1:GB","kind":"country-or-area","labels":{"ar":"المملكة المتحدة لبريطانيا العظمى وآيرلندا الشمالية","en":"United Kingdom of Great Britain and Northern Ireland","es":"Reino Unido de Gran Bretaña e Irlanda del Norte","fr":"Royaume-Uni de Grande-Bretagne et d’Irlande du Nord"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000349","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"]}],"method":"controlled-rules-v1","rule_id":"business-broad","status":"candidate"},{"concept_id":"medtop:20000178","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: reported and core operating profit","source_urls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"]}],"method":"controlled-rules-v1","rule_id":"corporate-results","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=en","category":"business","content":{"key_points":[],"paragraphs":["GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit fell 18% at actual exchange rates to 2.127 billion pounds.","Core operating profit rose 3% at actual exchange rates to 3.076 billion pounds, or 5% at constant exchange rates. The company linked the difference between total and core performance partly to restructuring charges of 328 million pounds and lower other net operating income. Core results are non-IFRS measures and do not replace reported results.","GSK reaffirmed full-year guidance for turnover growth of 3–5% and core operating profit growth of 7–9%, both at constant exchange rates. These expectations are forecasts. Currency-adjusted growth, reported growth and the company’s core measures describe different comparisons and should not be combined into one profit figure."],"sections":[]},"corrections":[],"country":"GB","data":{"blocks":[{"description":{"ar":"نشر الإعلان الرسمي في 28 أكتوبر 2026.","de":"Veröffentlichung der offiziellen Mitteilung am 28. Oktober 2026.","en":"Publication of the official announcement on 28 October 2026.","es":"Publicación del anuncio oficial el 28 de octubre de 2026.","fr":"Publication de l’annonce officielle le 28 octobre 2026.","pt":"Publicação do anúncio oficial em 28 de outubro de 2026.","tr":"Resmî duyurunun 28 Ekim 2026’da yayımlanması."},"id":"source-announcement","items":[{"date":"2026-10-28","description":{"ar":"أعلنت جي إس كي في 28 أكتوبر عن مبيعات للربع الثالث بلغت 8.887 مليارات جنيه إسترليني، بزيادة 4% بأسعار الصرف الفعلية و5% بأسعار الصرف الثابتة. وانخفض إجمالي الربح التشغيلي 18% بأسعار الصرف الفعلية إلى 2.127 مليار جنيه.","de":"GSK meldete am 28. Oktober für das dritte Quartal einen Umsatz von 8,887 Milliarden Pfund, ein Plus von 4 Prozent zu tatsächlichen Wechselkursen und 5 Prozent zu konstanten Wechselkursen. Der gesamte Betriebsgewinn sank zu tatsächlichen Wechselkursen um 18 Prozent auf 2,127 Milliarden Pfund.","en":"GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit fell 18% at actual exchange rates to 2.127 billion pounds.","es":"GSK informó el 28 de octubre de una facturación de 8.887 millones de libras en el tercer trimestre, un 4% más a tipos de cambio reales y un 5% a tipos de cambio constantes. El beneficio operativo total cayó un 18% a tipos reales, hasta 2.127 millones de libras.","fr":"GSK a annoncé le 28 octobre un chiffre d’affaires de 8,887 milliards de livres au troisième trimestre, en hausse de 4 % aux taux de change réels et de 5 % à taux de change constants. Le bénéfice opérationnel total a diminué de 18 % aux taux réels, à 2,127 milliards de livres.","pt":"A GSK comunicou em 28 de outubro um volume de negócios de 8,887 mil milhões de libras no terceiro trimestre, mais 4% às taxas de câmbio reais e 5% às taxas constantes. O lucro operacional total caiu 18% às taxas reais, para 2,127 mil milhões de libras.","tr":"GSK, 28 Ekim’de üçüncü çeyrek cirosunu gerçek döviz kurlarıyla %4, sabit döviz kurlarıyla %5 artışla 8,887 milyar sterlin olarak bildirdi. Toplam faaliyet kârı gerçek kurlarla %18 düşerek 2,127 milyar sterline geriledi."},"label":{"ar":"مبيعات جي إس كي ترتفع مع تباين الربح التشغيلي المعلن والأساسي","de":"GSK-Umsatz steigt, während berichteter und bereinigter Betriebsgewinn auseinanderlaufen","en":"GSK sales rise as reported and core operating profit diverge","es":"Las ventas de GSK crecen mientras divergen el beneficio operativo declarado y el básico","fr":"Les ventes de GSK progressent tandis que les bénéfices opérationnels publié et courant divergent","pt":"Vendas da GSK sobem enquanto os lucros operacionais reportado e core divergem","tr":"GSK satışları artarken açıklanan ve temel faaliyet kârı farklı yönlerde seyretti"},"status":"occurred"}],"methodology":{"ar":"يسجل التاريخ نشر المصدر الرسمي المذكور، ولا يثبت اكتمال الإجراءات المستقبلية المعلنة.","de":"Das Datum bezeichnet die Veröffentlichung der genannten offiziellen Quelle. Es belegt nicht, dass angekündigte Maßnahmen abgeschlossen wurden.","en":"The date records publication of the cited official source. It does not establish completion of announced future actions.","es":"La fecha corresponde a la publicación de la fuente oficial citada. No confirma que se hayan completado las acciones anunciadas.","fr":"La date correspond à la publication de la source officielle citée. Elle ne confirme pas la réalisation des actions annoncées.","pt":"A data regista a publicação da fonte oficial citada. Não comprova a conclusão das ações anunciadas.","tr":"Tarih, belirtilen resmî kaynağın yayımlandığı günü gösterir; duyurulan gelecek eylemlerin tamamlandığını kanıtlamaz."},"sourceUrls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"],"title":{"ar":"نشر المصدر الرسمي","de":"Veröffentlichung der offiziellen Quelle","en":"Source publication","es":"Publicación de la fuente oficial","fr":"Publication de la source officielle","pt":"Publicação da fonte oficial","tr":"Resmî kaynağın yayımlanması"},"type":"events","updatedAt":"2026-10-28T19:38:33Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026/data/source-announcement?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026/data/source-announcement?lang=en&format=json"},"id":"source-announcement"}],"data_types":["events"],"editorial_illustration":{"alt":"Conceptual illustration of industry, engineering and logistics connections.","asset_id":"newsverum-v1-business","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","width":1536}],"width":1536},"event_id":"event-4abb730d-3957-5da7-a65c-e1e7abd6cc06","event_period":"2026-09","event_period_basis":"event-or-reference-period","id":"gsk-third-quarter-sales-total-core-profit-currency-2026","image":null,"importance":0.6,"language":"en","modified_at":"2026-10-28T19:46:24+00:00","publication_basis":"publication-record","published_at":"2026-10-28T19:46:24+00:00","reading_minutes":1,"region":"world","relations":[],"section_illustration":{"alt":"Conceptual illustration of industry, engineering and logistics connections.","asset_id":"newsverum-v1-business","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","width":1536}],"width":1536},"slug":"gsk-third-quarter-sales-total-core-profit-currency-2026","sources":[{"checkedAt":"2026-10-28","name":"GSK","publishedAt":"2026-10-28","url":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"}],"summary":"GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates.","text":"GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates.\n\nGSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit fell 18% at actual exchange rates to 2.127 billion pounds.\n\nCore operating profit rose 3% at actual exchange rates to 3.076 billion pounds, or 5% at constant exchange rates. The company linked the difference between total and core performance partly to restructuring charges of 328 million pounds and lower other net operating income. Core results are non-IFRS measures and do not replace reported results.\n\nGSK reaffirmed full-year guidance for turnover growth of 3–5% and core operating profit growth of 7–9%, both at constant exchange rates. These expectations are forecasts. Currency-adjusted growth, reported growth and the company’s core measures describe different comparisons and should not be combined into one profit figure.","title":"GSK sales rise as reported and core operating profit diverge","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/gsk-third-quarter-sales-total-core-profit-currency-2026"}],"url":"https://newsverum.com/en/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},"version":"1"}
